Literature DB >> 20524664

Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.

Olivia M Merkel1, Meredith A Mintzer, Damiano Librizzi, Olga Samsonova, Tanja Dicke, Brian Sproat, Holger Garn, Peter J Barth, Eric E Simanek, Thomas Kissel.   

Abstract

A family of triazine dendrimers, differing in their core flexibility, genen>an class="Species">ration number, and surface functionality, was prepared and evaluated for its ability to accomplish RNAi. The dendriplexes were analyzed with respect to their physicochemical and biological properties, including condensation of siRNA, complex size, surface charge, cellular uptake and subcellular distribution, their potential for reporter gene knockdown in HeLa/Luc cells, and ultimately their stability, biodistribution, pharmacokinetics and intracellular uptake in mice after intravenous (iv) administration. The structure of the backbone was found to significantly influence siRNA transfection efficiency, with rigid, second generation dendrimers displaying higher gene knockdown than the flexible analogues while maintaining less off-target effects than Lipofectamine. Additionally, among the rigid, second generation dendrimers, those with either arginine-like exteriors or peripheries containing hydrophobic functionalities mediated the most effective gene knockdown, thus showing that dendrimer surface groups also affect transfection efficiency. Moreover, these two most effective dendriplexes were stable in circulation upon intravenous administration and showed passive targeting to the lung. Both dendriplex formulations were taken up into the alveolar epithelium, making them promising candidates for RNAi in the lung. The ability to correlate the effects of triazine dendrimer core scaffolds, generation number, and surface functionality with siRNA transfection efficiency yields valuable information for further modifying this nonviral delivery system and stresses the importance of only loosely correlating effective gene delivery vectors with siRNA transfection agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524664      PMCID: PMC2914146          DOI: 10.1021/mp100101s

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  47 in total

1.  Erbin suppresses the MAP kinase pathway.

Authors:  Yang Z Huang; Mengwei Zang; Wen C Xiong; Zhijun Luo; Lin Mei
Journal:  J Biol Chem       Date:  2002-10-11       Impact factor: 5.157

2.  Sticky overhangs enhance siRNA-mediated gene silencing.

Authors:  Anne-Laure Bolcato-Bellemin; Marie-Elise Bonnet; Gaëlle Creusat; Patrick Erbacher; Jean-Paul Behr
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

3.  Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing.

Authors:  Hyejung Mok; Soo Hyeon Lee; Ji Won Park; Tae Gwan Park
Journal:  Nat Mater       Date:  2010-01-24       Impact factor: 43.841

Review 4.  Flexibility of DNA.

Authors:  P J Hagerman
Journal:  Annu Rev Biophys Biophys Chem       Date:  1988

5.  Computational insights into the interactions between DNA and siRNA with "rigid" and "flexible" triazine dendrimers.

Authors:  Giovanni M Pavan; Meredith A Mintzer; Eric E Simanek; Olivia M Merkel; Thomas Kissel; Andrea Danani
Journal:  Biomacromolecules       Date:  2010-03-08       Impact factor: 6.988

6.  PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.

Authors:  Xiao-Xuan Liu; Palma Rocchi; Fan-Qi Qu; Shu-Quan Zheng; Zi-Cai Liang; Martin Gleave; Juan Iovanna; Ling Peng
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

7.  Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16.

Authors:  Rafael Gras; Luis Almonacid; Paula Ortega; Maria J Serramia; Rafael Gomez; F Javier de la Mata; Luis A Lopez-Fernandez; M Angeles Muñoz-Fernandez
Journal:  Pharm Res       Date:  2008-11-25       Impact factor: 4.200

Review 8.  Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.

Authors:  Dana J Gary; Nitin Puri; You-Yeon Won
Journal:  J Control Release       Date:  2007-05-26       Impact factor: 9.776

9.  Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.

Authors:  Mahesh L Patil; Min Zhang; Oleh Taratula; Olga B Garbuzenko; Huixin He; Tamara Minko
Journal:  Biomacromolecules       Date:  2009-02-09       Impact factor: 6.988

10.  Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro.

Authors:  Amy C Richards Grayson; Anne M Doody; David Putnam
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.580

View more
  20 in total

1.  Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane.

Authors:  Jonathan E Zuckerman; Chung Hang J Choi; Han Han; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.

Authors:  Kevin J Polach; Majed Matar; Jennifer Rice; Gregory Slobodkin; Jeff Sparks; Richard Congo; Angela Rea-Ramsey; Diane McClure; Elaine Brunhoeber; Monika Krampert; Andrea Schuster; Kerstin Jahn-Hofmann; Matthias John; Hans-Peter Vornlocher; Jason G Fewell; Khursheed Anwer; Anke Geick
Journal:  Mol Ther       Date:  2011-10-11       Impact factor: 11.454

Review 3.  Theranostic nanoparticles for cancer and cardiovascular applications.

Authors:  Dan Wang; Bingbing Lin; Hua Ai
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

4.  Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems.

Authors:  Olivia M Merkel; Mengyao Zheng; Meredith A Mintzer; Giovanni M Pavan; Damiano Librizzi; Marek Maly; Helmut Höffken; Andrea Danani; Eric E Simanek; Thomas Kissel
Journal:  J Control Release       Date:  2011-02-20       Impact factor: 9.776

5.  Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.

Authors:  Yin Tang; Yang-Bing Li; Bo Wang; Ri-Yuan Lin; Mallory van Dongen; Danielle M Zurcher; Xiao-Yan Gu; Mark M Banaszak Holl; George Liu; Rong Qi
Journal:  Mol Pharm       Date:  2012-05-14       Impact factor: 4.939

6.  Targeting the blind spot of polycationic nanocarrier-based siRNA delivery.

Authors:  Mengyao Zheng; Giovanni M Pavan; Manuel Neeb; Andreas K Schaper; Andrea Danani; Gerhard Klebe; Olivia M Merkel; Thomas Kissel
Journal:  ACS Nano       Date:  2012-10-09       Impact factor: 15.881

7.  Star-shaped tetraspermine enhances cellular uptake and cytotoxicity of T-oligo in prostate cancer cells.

Authors:  Vidula Kolhatkar; Hiren Khambati; Asawari Lote; Peter Shanine; Thomas Insley; Soumyo Sen; Gnanasekar Munirathinam; Petr Král; Rohit Kolhatkar
Journal:  Pharm Res       Date:  2014-08-05       Impact factor: 4.200

8.  Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

Authors:  Subrata Patra; Brittany Kozura; Adela Y-T Huang; Alan E Enciso; Xiankai Sun; Jer-Tsong Hsieh; Chai-Lin Kao; Hui-Ting Chen; Eric E Simanek
Journal:  Org Lett       Date:  2013-07-19       Impact factor: 6.005

9.  Perfectly shaped siRNA delivery.

Authors:  Olivia M Merkel; Meredith A Mintzer; Eric E Simanek; Thomas Kissel
Journal:  Ther Deliv       Date:  2010-12

10.  PSMA-targeted theranostic nanoplex for prostate cancer therapy.

Authors:  Zhihang Chen; Marie-France Penet; Sridhar Nimmagadda; Cong Li; Sangeeta R Banerjee; Paul T Winnard; Dmitri Artemov; Kristine Glunde; Martin G Pomper; Zaver M Bhujwalla
Journal:  ACS Nano       Date:  2012-08-09       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.